| Primary |
| Drug Use For Unknown Indication |
22.9% |
| Breast Cancer |
13.6% |
| Metastases To Bone |
10.1% |
| Breast Cancer Metastatic |
9.3% |
| Prophylaxis |
8.5% |
| Osteoporosis |
7.0% |
| Pain |
4.7% |
| Multiple Myeloma |
3.9% |
| Product Used For Unknown Indication |
2.7% |
| Chemotherapy |
2.3% |
| Disease Progression |
2.3% |
| Plasmacytoma |
2.3% |
| Hypertension |
1.9% |
| Osteolysis |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Sleep Disorder |
1.6% |
| Constipation |
1.2% |
| Lung Cancer Metastatic |
1.2% |
| Analgesia |
0.8% |
| Analgesic Therapy |
0.8% |
|
| Osteonecrosis |
59.4% |
| Metastases To Bone |
6.7% |
| Osteonecrosis Of Jaw |
5.5% |
| Osteomyelitis |
2.4% |
| Tachycardia |
2.4% |
| Vomiting |
2.4% |
| Blood Creatinine Increased |
1.8% |
| Lenticular Opacities |
1.8% |
| Periodontitis |
1.8% |
| Pyrexia |
1.8% |
| Swelling |
1.8% |
| Tachypnoea |
1.8% |
| Toothache |
1.8% |
| Arthritis |
1.2% |
| Bone Pain |
1.2% |
| Death |
1.2% |
| Disease Progression |
1.2% |
| Epistaxis |
1.2% |
| Gastrointestinal Haemorrhage |
1.2% |
| Hepatitis |
1.2% |
|
| Secondary |
| Product Used For Unknown Indication |
24.9% |
| Metastases To Bone |
21.7% |
| Breast Cancer |
15.7% |
| Breast Cancer Metastatic |
13.4% |
| Disease Progression |
2.8% |
| Pain |
2.8% |
| Hypertension |
2.1% |
| Plasmacytoma |
2.1% |
| Breast Cancer Female |
1.8% |
| Breast Neoplasm |
1.8% |
| Depression |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Osteoporosis |
1.2% |
| Sleep Disorder |
1.2% |
| Constipation |
0.9% |
| Hyperthyroidism |
0.9% |
| Metastases To Liver |
0.9% |
| Multiple Myeloma |
0.9% |
| Prophylaxis |
0.9% |
| Lung Cancer Metastatic |
0.7% |
|
| Osteonecrosis |
27.6% |
| Osteonecrosis Of Jaw |
12.9% |
| Tooth Extraction |
12.1% |
| Metastases To Bone |
7.8% |
| Rash |
7.8% |
| Leukoencephalopathy |
3.4% |
| Vomiting |
3.4% |
| Tachypnoea |
2.6% |
| Tooth Disorder |
2.6% |
| Tooth Loss |
2.6% |
| Arthralgia |
1.7% |
| Epistaxis |
1.7% |
| Macular Oedema |
1.7% |
| Malignant Neoplasm Progression |
1.7% |
| Metastases To Central Nervous System |
1.7% |
| Osteomyelitis |
1.7% |
| Pain In Jaw |
1.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.7% |
| Polyneuropathy |
1.7% |
| Primary Sequestrum |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.1% |
| Breast Cancer |
16.0% |
| Product Used For Unknown Indication |
10.7% |
| Breast Cancer Metastatic |
8.1% |
| Hypertension |
7.1% |
| Metastases To Bone |
5.9% |
| Multiple Myeloma |
4.2% |
| Pain |
4.0% |
| Prophylaxis |
3.4% |
| Osteoporosis |
2.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Plasma Cell Myeloma |
1.6% |
| Renal Transplant |
1.2% |
| Nausea |
1.0% |
| Non-hodgkin's Lymphoma |
1.0% |
| Renal Cancer |
1.0% |
| Cardiac Failure |
0.8% |
| Coronary Artery Disease |
0.8% |
| Depression |
0.8% |
| Hyperuricaemia |
0.8% |
|
| Vomiting |
22.5% |
| Pulmonary Embolism |
8.8% |
| Dehydration |
5.0% |
| Radius Fracture |
5.0% |
| Skin Necrosis |
5.0% |
| Ventricular Tachycardia |
5.0% |
| Vith Nerve Paralysis |
5.0% |
| Disease Progression |
3.8% |
| Osteonecrosis Of Jaw |
3.8% |
| Pain |
3.8% |
| Pleural Effusion |
3.8% |
| Pyrexia |
3.8% |
| Renal Failure |
3.8% |
| Thoracic Vertebral Fracture |
3.8% |
| Thrombocytopenia |
3.8% |
| Toothache |
3.8% |
| Cytokine Release Syndrome |
2.5% |
| Diarrhoea |
2.5% |
| Hypothyroidism |
2.5% |
| Intracranial Tumour Haemorrhage |
2.5% |
|
| Interacting |
| Osteoporosis |
50.0% |
| Rheumatoid Arthritis |
50.0% |
|
|
